Make your money go further for just 25p per day

More than Money: Shield Therapeutics

It is very unusual to find a small British pharma company which has managed to get a drug approved in the US. Shield Therapeutics (LON: STX) will have defied the odds if it gets a positive response back from the FDA on 27 July. We spoke to the group's founder and chief executive about the challenges of getting a drug approved in the world's biggest healthcare market and the commercial opportunities for those that make it.


Sign up for more great content

Register to continue reading our content.

Get FREE access now

Already a member? Login


Previous article Next article

Have your say

Log in or register to view or add comments.

For access to the top news and insights from the investment world

REGISTER FREE

Become a Champion Investor for just £90 a year.
 
 

START FREE TRIAL

More on Shield Therapeutics PLC

More than Money: Shield Therapeutics

22/05/2019 · Podcasts

It is very unusual to find a small British pharma company which has managed to get…


More Podcasts

More than Money: Harvey Sinclair

03/03/2020 · eEnergy

More than Money: Andrew Vaughan

25/02/2020

More than Money: Ben Crawford

19/02/2020 · CentralNic